243 related articles for article (PubMed ID: 27342131)
1. The pecking order of skin Advanced Glycation Endproducts (AGEs) as long-term markers of glycemic damage and risk factors for micro- and subclinical macrovascular disease progression in Type 1 diabetes.
Monnier VM; Genuth S; Sell DR
Glycoconj J; 2016 Aug; 33(4):569-79. PubMed ID: 27342131
[TBL] [Abstract][Full Text] [Related]
2. Skin collagen fluorophore LW-1 versus skin fluorescence as markers for the long-term progression of subclinical macrovascular disease in type 1 diabetes.
Sell DR; Sun W; Gao X; Strauch C; Lachin JM; Cleary PA; Genuth S; ; Monnier VM
Cardiovasc Diabetol; 2016 Feb; 15():30. PubMed ID: 26864236
[TBL] [Abstract][Full Text] [Related]
3. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
[TBL] [Abstract][Full Text] [Related]
4. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.
Genuth S; Sun W; Cleary P; Gao X; Sell DR; Lachin J; ; Monnier VM
Diabetes; 2015 Jan; 64(1):266-78. PubMed ID: 25187362
[TBL] [Abstract][Full Text] [Related]
5. The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.
Monnier VM; Sell DR; Strauch C; Sun W; Lachin JM; Cleary PA; Genuth S;
J Diabetes Complications; 2013; 27(2):141-9. PubMed ID: 23153673
[TBL] [Abstract][Full Text] [Related]
6. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
[TBL] [Abstract][Full Text] [Related]
7. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
8. Intima-media thickness at different arterial segments in pediatric type 1 diabetes patients and its relationship with advanced glycation end products.
Lilje C; Cronan JC; Schwartzenburg EJ; Owers EM; Clesi P; Gomez R; Stender S; Hempe J; Chalew SA; Cardinale JP
Pediatr Diabetes; 2018 May; 19(3):450-456. PubMed ID: 28664608
[TBL] [Abstract][Full Text] [Related]
9. Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes.
Sveen KA; Dahl-Jørgensen K; Stensaeth KH; Angel K; Seljeflot I; Sell DR; Monnier VM; Hanssen KF
J Diabetes Complications; 2015 Apr; 29(3):407-12. PubMed ID: 25600701
[TBL] [Abstract][Full Text] [Related]
10. Dermal microvessel density and maturity is closely associated with atherogenic dyslipidemia and accumulation of advanced glycation end products in adult patients with type 1 diabetes.
Adamska A; Araszkiewicz A; Pilacinski S; Gandecka A; Grzelka A; Kowalska K; Malinska A; Nowicki M; Zozulinska-Ziolkiewicz D
Microvasc Res; 2019 Jan; 121():46-51. PubMed ID: 30312628
[TBL] [Abstract][Full Text] [Related]
11. Skin fluorescence as a clinical tool for non-invasive assessment of advanced glycation and long-term complications of diabetes.
Fokkens BT; Smit AJ
Glycoconj J; 2016 Aug; 33(4):527-35. PubMed ID: 27287226
[TBL] [Abstract][Full Text] [Related]
12. Collagen methionine sulfoxide and glucuronidine/LW-1 are markers of coronary artery disease in long-term survivors with type 1 diabetes. The Dialong study.
Holte KB; Svanteson M; Hanssen KF; Sveen KA; Seljeflot I; Solheim S; Sell DR; Monnier VM; Berg TJ
PLoS One; 2020; 15(5):e0233174. PubMed ID: 32401813
[TBL] [Abstract][Full Text] [Related]
13. Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications.
Monnier VM; Sun W; Sell DR; Fan X; Nemet I; Genuth S
Clin Chem Lab Med; 2014 Jan; 52(1):21-32. PubMed ID: 23787467
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review.
Bos DC; de Ranitz-Greven WL; de Valk HW
Diabetes Technol Ther; 2011 Jul; 13(7):773-9. PubMed ID: 21510765
[TBL] [Abstract][Full Text] [Related]
15. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
Monnier VM; Bautista O; Kenny D; Sell DR; Fogarty J; Dahms W; Cleary PA; Lachin J; Genuth S
Diabetes; 1999 Apr; 48(4):870-80. PubMed ID: 10102706
[TBL] [Abstract][Full Text] [Related]
16. Skin autofluorescence is associated with carotid intima-media thickness, diabetic microangiopathy, and long-lasting metabolic control in type 1 diabetic patients. Results from Poznan Prospective Study.
Araszkiewicz A; Naskret D; Zozulinska-Ziolkiewicz D; Pilacinski S; Uruska A; Grzelka A; Wegner M; Wierusz-Wysocka B
Microvasc Res; 2015 Mar; 98():62-7. PubMed ID: 25582078
[TBL] [Abstract][Full Text] [Related]
17. Advanced Glycation End Products, Oxidation Products, and the Extent of Atherosclerosis During the VA Diabetes Trial and Follow-up Study.
Saremi A; Howell S; Schwenke DC; Bahn G; Beisswenger PJ; Reaven PD;
Diabetes Care; 2017 Apr; 40(4):591-598. PubMed ID: 28148544
[TBL] [Abstract][Full Text] [Related]
18. Skin autofluorescence and risk of micro- and macrovascular complications in patients with Type 2 diabetes mellitus-a multi-centre study.
Noordzij MJ; Mulder DJ; Oomen PH; Brouwer T; Jager J; Castro Cabezas M; Lefrandt JD; Smit AJ
Diabet Med; 2012 Dec; 29(12):1556-61. PubMed ID: 22937960
[TBL] [Abstract][Full Text] [Related]
19. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.
Lyons TJ; Bailie KE; Dyer DG; Dunn JA; Baynes JW
J Clin Invest; 1991 Jun; 87(6):1910-5. PubMed ID: 1904067
[TBL] [Abstract][Full Text] [Related]
20. Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease.
Hofmann B; Jacobs K; Navarrete Santos A; Wienke A; Silber RE; Simm A
Diabetes Metab; 2015 Nov; 41(5):410-5. PubMed ID: 25553578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
